Oncoloxía médica

2023

1. Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (Scientific Reports, (2015), 5, 1, (17499), 10.1038/srep17499)

   Scientific Reports

2. Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (Clinical and Translational Oncology, (2023), 25, 9, (2679-2691), 10.1007/s12094-023-03216-3)

   Clinical and Translational Oncology

3. Erratum: Correction: Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer (Cancer research (2017) 77 21 (5846-5859))

   Cancer research

4. Erratum: Effectiveness of a novel gene nanotherapy based on putrescine for cancer treatment (Biomaterials Science (2023) DOI: 10.1039/d2bm01456d

   Biomaterials Science

5. Expanding genetic diversity and polygenic risk scores application in rheumatic disease studies: a call for inclusive research

   The Lancet Rheumatology

6. HLA alleles: important pieces to the COVID-19 puzzle

   Trends in Immunology

7. Liquid Biopsy Assessment of Molecular Residual Disease in Localized Colorectal Cancer: Is It Ready for Prime Time?

   JAMA Oncology

8. Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer (Scientific Reports, (2023), 13, 1, (15401), 10.1038/s41598-023-42037-w)

   Scientific Reports

9. Rapid Idylla mutational testing to detect EGFR mutations in plasma samples and to monitor therapy in advanced non-small cell lung cancer patients

   Pathology

10. SEOM 2022 clinical guidelines

    Clinical and Translational Oncology

11. Top-of-The-Art cytometry as a novel tool to aid in lung cancer immunotherapy

    Translational Lung Cancer Research